OOIR: Observatory of International Research

Papers

(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health	77
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study	64
Quality of Care and Long-term Survival After ST-elevation Myocardial Infarction in Adults with Cancer	55
Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis	45
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	36
COP27 Climate Change Conference: urgent action needed for Africa and the world	35
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	35
Global burden of heart failure and its underlying causes in 204 countries and territories, 1990–2021	34
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten	32
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study	32
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	30
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	30
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease	30
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	29
Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations	29
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	27
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data	25
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease	23
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	22
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction	22
Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population	22
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease	22
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	21
Impact of age on outcomes after transcatheter aortic valve implantation	21
Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?	21

Letter to the editor in response to Kobo et al. (2022)	20
Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study	20
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	19
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the Eur	19
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis	19
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	18
Letter to the editor in response to Kobo et al. 2022	17
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO	17
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	17
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	17
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	16
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study	16
The impact of atrial fibrillation on prognosis in aortic stenosis	16
Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study	16
Defining the need for cardiovascular event definitions	15
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	15
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	15
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	15
Ambulance drive-thru troponin, ready to go?	14
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	14
Stroke outcomes in patients with new onset perioperative atrial fibrillation complicating major abdominal surgery compared with patients with new onset non-perioperative atrial fibrillation	14
Secundum atrial septal defect closure in adults in the UK	14
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	13
Early goal-directed management after out-of-hospital cardiac arrest: lessons from a certified cardiac arrest centre	13
Serial cardiopulmonary exercise testing in young patients after one-and-half ventricle repair and Fontan procedure: a comparative study	13
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	12
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	12
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	12
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017	11
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	11
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	11
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	11
Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	11
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	11
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	11
Quality indicators for improved cardiovascular care: learnings from the National Institute for Health and Care Excellence	11
Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden	10
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk	10
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	10
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	10
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	9
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	9
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	9
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus	9
A hidden problem: peripheral artery disease in women	9
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017	8
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	8
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study	8
Reducing the risks of nuclear war: the role of health professionals	8
Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis	8

Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	8
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	8
Economic burden of cardiovascular disease in the United Kingdom (UK)	8
The utility of implantable loop recorders in patient management: an age- and indication-stratified study in the outpatient-implant era	8
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	8
Regional disparities in heart transplant mortality in the USA	8
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom	7
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients	7
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	7
Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition	7
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	7
Integrating patient-reported outcome measures in congenital heart disease care	7
Quality of life and the assessment of surgical quality	7
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	7
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	7
Discharge after primary percutaneous coronary intervention: the earlier the better?	7
Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement	7
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis	7
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation	7
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7